Strategies for Engineering Human Chromosomes with Therapeutic Potential
Overview
Molecular Biology
Authors
Affiliations
Human engineered chromosomes (HECs) have several potential advantages over currently used vectors for gene therapy applications. Firstly, there is no upper size limit to DNA that can be cloned in these vectors. Secondly, their extrachromosomal nature ensures that introduced genes are neither disruptive to, nor affected by, the genome of the host cell. Finally, being solely human in origin, HEC vectors should not evoke adverse host immunogenic responses. Recent advances have produced a variety of HECs via several different approaches. This review focuses on the current methodologies for making HEC vectors, the advantages and problems associated with each strategy, and discusses the outlook for HEC vectors as ex vivo therapeutic agents.
Using human artificial chromosomes to study centromere assembly and function.
Molina O, Kouprina N, Masumoto H, Larionov V, Earnshaw W Chromosoma. 2017; 126(5):559-575.
PMID: 28688039 DOI: 10.1007/s00412-017-0633-x.
Minichromosomes and artificial chromosomes in Arabidopsis.
Murata M Chromosome Res. 2014; 22(2):167-78.
PMID: 24788232 DOI: 10.1007/s10577-014-9421-0.
Protecting a transgene expression from the HAC-based vector by different chromatin insulators.
Lee N, Kononenko A, Lee H, Tolkunova E, Liskovykh M, Masumoto H Cell Mol Life Sci. 2013; 70(19):3723-37.
PMID: 23677492 PMC: 3771377. DOI: 10.1007/s00018-013-1362-9.
Kononenko A, Lee N, Earnshaw W, Kouprina N, Larionov V Nucleic Acids Res. 2013; 41(10):e107.
PMID: 23558748 PMC: 3664798. DOI: 10.1093/nar/gkt205.
A new generation of human artificial chromosomes for functional genomics and gene therapy.
Kouprina N, Earnshaw W, Masumoto H, Larionov V Cell Mol Life Sci. 2012; 70(7):1135-48.
PMID: 22907415 PMC: 3522797. DOI: 10.1007/s00018-012-1113-3.